Bisphosphonate-related osteonecrosis of the jaw combined with jaw metastasis of prostate adenocarcinoma: report of a case.
Frei
Marc
M
Department of Oral Surgery and Stomatology, School of Dental Medicine, University of Bern, Bern, Switzerland.
Bornstein
Michael M
MM
Schaller
Benoit
B
Reichart
Peter A
PA
Weimann
Rosemarie
R
Iizuka
Tateyuki
T
D000230:Adenocarcinoma / Q000150:complications / Q000188:drug therapy / Q000556:secondary*; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D008297:Male; D008336:Mandibular Diseases / Q000139:chemically induced / Q000150:complications* / Q000601:surgery; D008339:Mandibular Neoplasms / Q000150:complications / Q000188:drug therapy / Q000556:secondary*; D008875:Middle Aged; D010020:Osteonecrosis / Q000139:chemically induced / Q000150:complications* / Q000601:surgery; D011471:Prostatic Neoplasms / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid